Cargando…
Clinical Outcomes in Hospitalized Vaccine-Breakthrough Coronavirus Disease 2019 Cases Compared With Contemporary Unvaccinated Hospitalized Adults
The inactivatedsevere acute respiratory syndrome coronavirus 2 vaccine (CoronaVac) has been the principal vaccine used in Chile’s prebooster immunization campaign. We compared major outcomes in 206 hospitalized vaccinated adults vs 507 unvaccinated adults (mid-2021). Individuals in the vaccinated gr...
Autores principales: | Wolff, Marcelo, Gilabert, Margarita, Hernández, Rodrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963676/ https://www.ncbi.nlm.nih.gov/pubmed/35360196 http://dx.doi.org/10.1093/ofid/ofac122 |
Ejemplares similares
-
Secondary Cases of Delta Variant Coronavirus Disease 2019 Among Vaccinated Healthcare Workers With Breakthrough Infections is Rare
por: Waldman, Sarah E, et al.
Publicado: (2021) -
Vaccine breakthrough infections in veterans hospitalized with coronavirus infectious disease-2019: A case series
por: Kim, Paul S., et al.
Publicado: (2022) -
Breakthrough Infections: Clinical Profile and Outcomes of COVID-19 Vaccinated and Unvaccinated People From a Tertiary Care Hospital
por: Shahapur, Praveen R, et al.
Publicado: (2022) -
Characteristics of Postvaccination Coronavirus Disease 2019 Hospitalizations Prior to Booster Vaccines
por: Moffa, Matthew A, et al.
Publicado: (2022) -
Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults
por: Bruxvoort, Katia J, et al.
Publicado: (2021)